Opinion Article - Current Trends in Cardiology (2023) Volume 7, Issue 4

Cardiac Tumours: Treatment Options and Prognosis

Byoung Choi^*

Department of Radiology, Yonsei University, Seoul, Republic of Korea.

*Corresponding Author:

Madan Rehani
Department of Radiology
Yonsei University
Seoul, Republic of Korea.
E-mail:Byoungchoi@gmail.com

Received:30-Mar-2023, Manuscript No. AACC-23-97854; Editor assigned: 03-Apr-2023,PreQC No. AACC-23-97854(PQ); Reviewed:17-Apr-2023,QC No. AACC-23-97854; Revised:21-Apr-2023, Manuscript No. AACC-23-97854(R); Published:27-Apr-2023,DOI:10.35841/aarrgs-7.4.154

Citation: Choi B. Cardiac tumours: treatment options and prognosis. J Cell Biol Metab. 2023;7(4):154.

Abstract

Cardiac tumours are abnormal growths that develop in the heart or the tissues surrounding the heart. These tumours can be either benign or malignant, and can cause a range of symptoms and complications, including heart failure, arrhythmias, and stroke. Cardiac tumours are relatively rare, accounting for less than 5% of all cardiac diseases. However, early diagnosis and treatment are crucial for improving the prognosis and preventing serious complications.

Keywords

Arrhythmias, Cardiac tumors, Incessant tachycardias, Pediatric arrhythmias, Sudden death.

Introduction

Types of cardiac tumors

There are several different types of cardiac tumours, which can be classified based on their location, size, and whether they are primary or secondary tumours. Primary tumours originate in the heart itself, and are further divided into two subtypes: benign and malignant. The most common benign cardiac tumor is the myxoma, which accounts for around 50% of all primary cardiac tumours. Myxomas are usually located in the left atrium, and can cause symptoms such as shortness of breath, palpitations, and dizziness. Malignant primary cardiac tumours, such as sarcomas, are much less common, accounting for less than 5% of cases. These tumours can invade surrounding tissues and spread to other parts of the body, making them much more dangerous than benign tumours. Secondary tumors, also known as metastatic tumors, are those that originate in another part of the body and spread to the heart. These tumors are much more common than primary cardiac tumours, and can be caused by a range of cancers, including lung, breast, and melanoma. The most common location for secondary tumors in the heart is the pericardium, the sac that surrounds the heart.

Sudden onset of heart failure

Diagnosis of cardiac tumors can be challenging, as many of the symptoms are nonspecific and can be caused by other conditions. However, a thorough medical history, physical examination, and diagnostic tests can help to identify the presence of a cardiac tumor Imaging tests, such as echocardiography, CT scan, or MRI, can provide detailed images of the heart and surrounding tissues, allowing doctors to identify the location and size of any tumors. Blood tests, including tumor markers and cardiac biomarkers, can also be used to help diagnose and monitor the progression of cardiac tumors [1].

Treatment and Prognosis

The treatment of cardiac tumors depends on several factors, including the type and location of the tumor, the size and extent of the tumor, and the overall health of the patient. Treatment options for cardiac tumors include surgery, chemotherapy, radiation therapy, and targeted therapy. Surgery is often the preferred treatment for primary cardiac tumors, as it can provide a complete cure for many patients. However, the location and size of the tumor can make surgery challenging, and in some cases, surgery may not be possible [2].

Chemotherapy and radiation therapy are often used to treat malignant cardiac tumors, as they can help to shrink the tumor and slow its progression. Targeted therapy, which uses drugs that specifically target cancer cells, can also be used to treat some types of cardiac tumors. The prognosis for cardiac tumors depends on several factors, including the type and location of the tumor, the extent of the disease, and the overall health of the patient. Benign tumors, such as myxomas, have a good prognosis if they are detected early and treated promptly. Malignant tumors, on the other hand, are much more difficult to treat, and the prognosis is often poor. Essential cardiovascular cancers in youngsters are really uncommon in general, which harmless record for most part. The beginning of the infection is mysterious, while the clinical indications are vague patients might be asymptomatic or show a scope of obstructive, arrhythmic, embolic or fundamental side effects. The clinical introductions for the most part rely upon the cancers' size, confinement, and speed of development of the growth. Besides, the determination needs far reaching judgment in view of imaging results and neurotic assessment. With propels in cardiovascular envisioning and the presentation of cardiopulmonary help, the analysis and treatment of these uncommon growths have worked on the visualization and standpoint for harmless cancers [3].

Cardiovascular attractive reverberation (CMR) offers better benefits in heart imaging due than providing a more prominent field of view, brilliant delicate tissue imaging, and multiplanar imaging capacities. CMR imaging can assess the qualities of heart growths by envisioning the connection between the growth and encompassing tissues, and assumes an essential part in helping the definition of the careful arrangement, the evaluation of cancer movement, and the checking of postoperative growth repeat and metastasis. In this audit, we present the clinical signs and imaging highlights of various cardiovascular growths. Cardiovascular growths are an uncommon reason for arrhythmias in clinical practice. [4].

Treatment of Myocardial Dysfunction:

They can cause a wide range of arrhythmias, from low?grade ectopics to perpetual ventricular tachycardias, including unexpected heart failure. Both essential and optional cardiovascular growths can create arrhythmias, however not all cancers cause arrhythmias. Albeit cardiovascular growths can cause arrhythmias in hatchlings and more seasoned grown-ups the same, just unambiguous heart growths are the fundamental reason for arrhythmia in various age gatherings. This article audits different heart growths that are related with arrhythmias, their clinical introductions, indicative elements, and the board [5].

Conclusion

Cardiac tumours are a rare but serious condition that can cause a range of symptoms and complications, including heart failure, arrhythmias, and stroke. Early diagnosis and treatment are crucial for improving the prognosis and preventing serious complications. Primary cardiac tumours are relatively uncommon, with myxomas being the most common benign tumour and sarcomas being the most common malignant tumour. Secondary cardiac tumours, which originate in another part of the body and spread to the heart, are more common and can be caused by a range of cancers. Diagnosis of cardiac tumours can be challenging, as many of the symptoms are nonspecific and can be caused by other conditions. Imaging tests, such as echocardiography, CT scan, or MRI, can provide detailed images of the heart and surrounding tissues, allowing doctors to identify the presence of a cardiac tumour. Treatment options for cardiac tumours include surgery, chemotherapy, radiation therapy, and targeted therapy. The choice of treatment depends on several factors, including the type and location of the tumour, the size and extent of the tumour, and the overall health of the patient.

References

1. Lee KJ. A case of arteriovenous type cardiac hemangioma. Korean J Intern Med. 1998;13:123-6.

Indexed at, Google Scholar, Cross Ref

2. Wang Y. Cardiac hemangioma caused ventricular arrhythmia: a rare case and literature review.. J Electrocardiol. 2017;50:667–70.

Indexed at, Google Scholar,Cross Ref

3. Abu?Omar Y. Intractable ventricular tachycardia secondary to cardiac hemangioma.. Ann Thorac Surg. 2010;90:1347–49.

Google Scholar, Cross Ref

4. Luna A. Evaluation of cardiac tumours with magnetic resonance imaging.. Eur Radiol. 2005;15:1446–55.

Indexed at, Google Scholar,

5. Becker AE. Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. Pediatr Cardiol. 2000;21:317–23.

Indexed at, Google Scholar,